Last reviewed · How we verify

NCT04986553

A Multi-Center, Prospective Registry to Evaluate the Continued Safety and Performance of Clavicle Plates

Withdrawn Last updated 1 February 2024
What this trial tests

trial testing Arthrex Clavicle Plates in Clavicle Fracture. Withdrawn.

Timeline
20 May 2021
Primary endpoint
30 July 2023
30 July 2023

Quick facts

Lead sponsorArthrex, Inc.
StatusWithdrawn
Study typeOBSERVATIONAL
Start date20 May 2021
Primary completion30 July 2023
Estimated completion30 July 2023
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arthrex, Inc. — full company profile →

Who can join

18 and older, any sex, with Clavicle Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the registry is to evaluate the continued safety and performance of Arthrex Clavicle Plates used to treat clavicle fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Clavicle Fracture

Currently open trials in the same condition.

Other Arthrex, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04986553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing